Clinical Trial Update: Evaluation of the Immune Response of a HIV Candidate Vaccine After Administration of One Chloroquine Dose [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immune response to an HIV candidate vaccine after a single chloroquine dose has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV candidate vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: AIDS | Phase 2 | Status: COMPLETED | Results posted: 2017-04-13